ArticleFrontiers in immunology2026

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer.

Su Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.